SBRASabra Health Care REIT, Inc.

$18.97+6.1% 1Y

Is it safe?

Mixed

Nothing alarming, nothing pristine: insiders quiet, comfortable debt (A), and steady price behavior.

1 good, 2 neutral, 3 without data
Insider conviction-$4.2MSEC EDGAR · Oct 8, 2026

Insiders were net sellers (-$4.2M, 90 days to Oct 8, 2026), selling is often routine.

Credit gradeAderived · Jun 30, 2026

Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.

Drawdown risk24% volderived · Oct 9, 2026

Relatively steady, low volatility. Worst drawdown -75% · now 15% below its 52-week high.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitytop 9% of the market
Max drawdownmiddle of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can SBRA take a bad year?

The deepest fall in SBRA's price history on file is −75%; it is 15% below its high today.

$2.39B

Net debt · as at Q2 2026 · debt less the cash on hand

Cash runway
0.8 years

Cash runway · burning $78M a quarter at the current rate

Annualised volatility
24%

Annualised volatility · about as steady as the market itself

Worst drawdown on file
−75%

Worst drawdown on file · −15% today

Details›
Total debtQ2 2026
$2.63B
Cash and short-term investments
$232M
Net debt
$2.39B
Debt / equity
0.95×
Annualised volatilitytwo years of daily moves
24%
Worst drawdown on file
−75%
Below its 52-week high
15%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.